Telefon: 06192 200550            kontakt@praxis-gueltekin.de

Wissenschaftliche Publikationen 

Hinweis: Ausgewählte wissenschaftliche arbeiten von Dr. F. Gültekin (früher veröffentlicht unter dem Namen Duygu F.)

 

 

  1. Duygu F, Sari T, Kaya T, Tavsan O, Naci M. The Relationship Between Crimean-Congo Hemorrhagic Fever And Climate:Does Climate Affect The Number Of Patients? Acta Clin Croat. 2018 Sep;57(3):443-448. Doi: 10.20471/Acc.2018.57.03.06. Pubmed Pmid: 31168176; Pubmed             Central Pmcıd: Pmc6536269.
  2. Duygu F, Sari T, Celik H. Effects of platelet function on the haemorrhagic manifestations and mortality in Crimean-Congo haemorrhagic fever. Infez Med. 2018 Dec 1;26(4):341-346. PubMed PMID: 30555138.
  3. Duygu F, Sari T, Gunal O, Barut S, Atay A, Aytekin F. Cutaneous Findings of Crimean-Congo Haemorrhagic Fever: A Study of 269 Cases. Jpn J Infect Dis. 2018 Jun 29. doi: 10.7883/yoken.JJID.2018.005.
  4. Barut S, Gemici Ü, Güneş F, Demir O, Duygu F. Predictors of histological indication for treatment in HBeAg negative chronic HBV infection. J Med Virol. 2017 Jun 15. doi: 10.1002/jmv.24879.
  5. Duygu F, Sari T, Kaya T, Bulut N. Brucellosis in Patientswith Crimean-Congo Hemorrhagic Fever. J Arthropod Borne Dis. 2017 Dec 30;11(4):463-468. eCollection 2017 Dec.
  6. Z Özmen,E Albayrak, ZC Özmen, F Aktaş, T Aktas, F Duygu. The evaluation of abdominal findings in Crimean-Congo hemorrhagic fever. Abdominal Radiology 2016; 41 (2), 384-390
  7. I Butun, S Sahin, F Duygu. Evaluation of some thymus proteins in patients with Crimean Congo hemorrhagic fever. Febs Journal 2016;283, 219-219. Karakus N, Yigit S, Kocak M, Bozkurt N, Duygu F. Impact of methylene-tetrahydrofolate reductase gene C677T and A1298C polymorphisms as a risk factor for hepatitis B virus infection. Nucleosides Nucleotides            Nucleic Acids. 2023;42(9):683-695. doi: 10.1080/15257770.2023.2187061. Epub 2023 Mar 15. PMID: 36919686.
  8. Aytekin FY, Barut HŞ, Rüstemoğlu A, Atay A, Günal Ö, Duygu F. Factorsrelated to fatalities and clinical progression of Crimean-Congo hemorrhagic fever patients and the effects of IL 28-B gene polymorphism. Arch Virol. 2019 Feb;164(2):547-557. doi: 10.1007/s00705-018-4106-1. Epub 2018 Nov 26. PubMed PMID: 30478788.
  9. Ceken S, İskender G, Ogan MC, Yenigun A, Duygu F. Leuconostoc Pseudomesenteroides Bacteremiae In A Patient With Malignancy: A Case Presentation. Mediterr J Infect Microb Antimicrob 2015;4:6 DOI: 10.4274/mjima.2015.6
  10. Günal O, Barut S, Ayan M, Kılıç S, Duygu F. Investigation of Coxiella burnetii and Brucella seropositivities in patients presenting with acute fever. Mikrobiyol Bul. 2013 Apr;47(2):265-72.
  11. Duygu F, Aksoy N, Cicek Copur A, Butun I, Unlu S. Does Prolidase Indicate Worsening Of Hepatitis B Infection. J Clin Lab Anal. 2013 Sep;27(5):398-401. doi: 10.1002/jcla.21617
  12. Duygu F, Karsen H, Aksoy N, Taskin A. Relationship of Oxidative Stress in Various Forms of Hepatitis B Infection with DNA and Fibrosis. Ann Lab Med 2012; Mar;32(2):113-118. DOI: 10.3343/alm.2012.32.2.113.
  13. Karsen H, Koruk ST, Calisir C, Karagac L, Duygu F. A case of brucellosis complicated with fatal capillary leak syndrome. Bratisl Lek Listy. 2012;113(8):511-3.DOI:10.4149/BLL_2012_115
  14. Duygu F, KorukST, Aksoy N. Serum paraoxonase and arylesterase activities in variousforms of hepatitis B virus infection. J Clin Lab Anal. 2011;25(5):311-6.
  15. Koc S, Uysal IO, Uysal EB, Yenişehirli G, Duygu F. The comparison of bacteremia and amount of bleeding during septoplasty. Eur Arch Otorhinolaryngol 2012;269:1139–1142 DOI: 10.1007/s00405-011-1789-2.
  16. Çiçek AÇ, Duygu F. Investigation of Toxoplasma gondiiantibodies with ELISA among women of childbearing age in Şanlıurfaprovince: A three years evaluation. Dicle Med J 2012;39(2):      174-178. doi:10.5798/diclemedj.0921.2012.02.0122
  17. Duygu F, Kaya T. Is Blood Type Associated with Mortality In Crimean-Congo Haemorrhagic Fever? Journal of Microbiology and Infectious Diseases 2011; 1 (3): 118-121. doi: 10.1089/vbz.2011.0694.
  18. Duygu F, Koruk ST, Aksoy N, TaskinA, Hamidanoglu M. Prolidase and oxidative stressin chronic hepatitis C. J Clin Lab Anal. 2012 Jul;26(4):232-7. doi: 10.1002/jcla.21510.
  19. Duygu F, KayaT, Baysan P. Re-Evaluation of 400 Crimean-CongoHemorrhagic Fever Cases in an Endemic Area: Is Ribavirin Treatment Suitable? Vector Borne Zoonotic Dis. 2011 Oct 18. DOI: 10.1089/vbz.2011.0694.
  20. Kuzi S, Duygu F, Sencan I. Investigation of Influenza Cases and Risk Factors Associated with Fatality in Türkiye. Sisli Etfal Hastan Tip Bul. 2025 Mar 18;59(1):50-58. doi: 10.14744/SEMB.2024.64614. PMID: 40226551; PMCID: PMC11983025.
  21. Sarıgül Yıldırım F, Üser Ü, Sarı ND, Kurtaran B, Önlen Y, Şenateş E, Gündüz A, Zerdali E, Karsen H, BatırelA, Karaali R, Güner R, Yamazhan T, Köse Ş, Erben N, İnce N, Köksal İ, Çuvalcı Öztoprak N, Yörük G, Kömür S, Bal T, Kaya S, Bozkurt İ, Günal Ö, Yıldız İE, İnan D, Barut Ş, Namıduru M, Tosun S, Türker K, Şener A, Hızel K, Baykam N, Duygu F, BodurH, Can G, Gül HC, Sağmak Tartar A, Çelebi G, Sünnetçioğlu M, Karabay O, Kumbasar Karaosmanoğlu H, SırmatelF, Tabak F. In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C inTurkey. Turk J Gastroenterol. 2022 Nov;33(11):971-978. doi: 10.5152/tjg.2022.21834. PMID: 36415900; PMCID: PMC9797763.
  22. Cag Y, Erdem H, Gunduz M, Komur S, Ankarali H, Ural S, Tasbakan M, Tattevin P, Tombak A, Ozturk-Engin D, Tartar AS, Batirel A, Tekin R, Duygu F, Caskurlu H, Kurtaran B, Durdu B, Haciseyitoglu D, Rello J; ID-IRI Mucormycosis Study Group. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study. Eur J Intern Med. 2022 Jun;100:56-           61. doi: 10.1016/j.ejim.2022.03.008. Epub 2022 Mar 15. PMID: 35304041.
  23.  Karakus N, Duygu F, Rustemoglu A, Yigit S. Methylene-tetrahydrofolate reductase gene C677T                and A1298C polymorphisms as a risk factor for Crimean-Congo hemorrhagic fever. Nucleosides              Nuc cleotides Nucleic Acids. 2022;41(9):878-890. doi: 10.1080/15257770.2022.2085296. Epub 2022              Jun 6. Erratum in: Nucleosides Nucleotides Nucleic Acids. 2022;41(11):1263-1264. doi:                 10.1080/15257770.2022.2101280. PMID: 35666819.   
  24. Çıtıl R, Egri M, Onder Y, Duygu F,Bulut YE, Yasayancan Ö, Yıldız ÇeltekN, Sahin S. Determination of Seroprevalence and Risk Factors of Crimean–Congo Haemorrhagic Fever (CCHF) in the Endemic Region in Turkey: A Population-Based Cross-Sectional Study. Journal of Tropical Medicine 2021(11):1-10. DOI: 10.1155/2021/9945089
  25. Carolin E. M. Jakob, Stefan Borgmann, Fazilet Duygu, Uta Behrends, Martin Hower, Uta Merle et all. First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)” Infection 2020 Oct 1;1-11. doi: 10.1007/s15010-020-01499-0
  26. Mert D, Ceken S, Iskender G, Iskender D, Merdin A, Duygu F, ErtekM, Altuntas F. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies. J Infect Dev Ctries. 2019 Aug 31;13(8):727-735. doi: 10.3855/jidc.11457. PubMed PMID: 32069257.
  27. Erdem H, Cag Y, Gencer S, Uysal S, Karakurt Z, Harman R, Aslan E, Mutlu-Yilmaz, E, Karabay O, Uygun Y, Ulug M, Tosun S, Dogru A, Sener A, Dogan M, Hasbun R, Durmus G, Turan H, Batirel A, Duygu F, Inan A, Akkoyunlu Y, Celebi G, Ersoz G, Guven T, Dagli O, Guler S, Meric-Koc M, Oncu S, Rello J. Treatmentof ventilator-associated pneumonia(VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):45-52. doi: 10.1007/s10096-019-03691-z. Epub 2019 Sep 9. PubMed PMID: 31502120.
  28. Karakus N, Yigit S, Duygu F, Barut S, Rustemoglu A, Basol N. Effects of Paraoxonase-1 variants on course of severity and mortality of Crimean-Congo hemorrhagic fever. Gene. 2019 Mar 1;687:188-192. doi: 10.1016/j.gene.2018.11.059.
  29. Çeken S, İskender G, Gedik H, Duygu F, Mert D, Kaya AH, Altuntaş F, Ertek M. Risk factors for bloodstream infections due to extended-spectrum β-lactamase producingEnterobacteriaceae in cancer patients journal of Infection in Developing Countries Vol 12 No 04: April 2018
  30. K Aytekin, Ş Direkel, B Kır, M Uysal, FY Aytekin, F Duygu, C Zeki. Efficacy of the use of sterile plastic to cover the surgical field against infection in orthopedic operations. J Contemp Med 2018; 8, 1.
  31. Rustemoglu A, Ekinci D, Nursal AF, Barut S, Duygu F, Günal Ö. The possible role of CCR5Δ32 mutation in Crimean-Congo hemorrhagic fever infection. J Med Virol. 2017 Oct;89(10):1714- 1719. doi: 10.1002/jmv.24865
  32. Fletcher TE, Gulzhan A, Ahmeti S, Al-Abri SS, Asik Z, Atilla A, Beeching NJ, Bilek H, Bozkurt I, Christova I, Duygu F, Esen S, Khanna A, Kader Ç, Mardani M, Mahmood F, Mamuchishvili N, Pshenichnaya N, Sunbul M, Yalcin TY, Leblebicioglu H. Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia. PLoS One. 2017 Sep 8;12(9):e0182315. doi: 10.1371/journal.pone.0182315. eCollection 2017.
  33. Aktaş F, Özmen Z, Altunkaş A, Albayrak E, Duygu F, Demir O, Özmen ZC. Is hemorrhage the reason in crimean-congo hemorrhagic fever patients with neurological signs and symptomsa. Niger J Clin Pract. 2017 Oct;20(10):1294-1301. doi: 10.4103/njcp.njcp_443_16.
  34. D Aksoy, H Barut, F Duygu, B Çevik, S Kurt, O Sümbül. Characteristics of headache and its relationship to diseaseseverity in patientswith Crimean-Congo hemorrhagic fever. The Journal of The Turkish Society of Algology, 2017; 30 (1),1
  35. Albayrak E, Duygu F, Demir O. Is hemorrhage the reason in crimean-congo hemorrhagic fever patients with neurological signs and symptomsa. Nigerian journal of clinical practice 20 (10), 1294-1294
  36. Hatipoglu M, Mutluoglu M, Turhan V, Uzun G, Lipsky BA; Turk-Day Study Group., Sevim E, Demiraslan H, Eryilmaz E, OzuguzC, Memis A, Ay H, Arda B, Uysal S, Motor VK, Kader C, Erturk A, Coskun O, Duygu F, Guler S, Altay FA, Ogutlu A, Bolukcu S, Yildiz S, Kandemir O, Aslaner H, Polat A, Karahocagil MK, Yasar KK, Sehmen E, Kilic S, Sunbul M, Gencer S, Bozkurt F, Yanik T, Oztoprak N, Batirel A, Sozen H, Kilic I, Celik I, Ay B, Tosun S, Kadanali A, Çomoglu S, Denk A, Hosoglu S, Aydin O, Elaldi N, Akalin S, Kandemir B. Causative pathogens and antibioticresistance in diabetic foot infections: Aprospective multi-center study. Akbulut A, Demirdal T, Balik R, Azak E, Sengoz G. J Diabetes Complications. 2016 Jul;30(5):910-6. doi: 10.1016/j.jdiacomp.2016.02.013.
  37. FY Aytekin, S Barut, A Rustemoglu, O Gunal, F Duygu, AD Yalcin. The relationship between Crimean-Congo hemorrhagic fever virus and IL-28B gene polymorphism. Allergy2016; 71, 151- 151
  38. Gunal O, Yigit S, Yalcın AD, Celik B, Barut S, Demir O, Ates O, Duygu F, Kaya S, Rustemoglu A, Sezer O. The IL4-VNTR P1 allele, IL4-VNTR P2P2 genotype and IL4-VNTR_IL6-174CG P2P1-GG genotype are susceptable with a increased risk in Brucelosis. Jpn J Infect Dis. 2016 May 9.
  39. Kaya AH, TekgündüzE, Duygu F, İskender D, Bekdemir F, Batgi H, Ulu BU, Yiğenoğlu TN, Altuntas F. Risk adapted management of febrile neutrepenia in hematopoietic stem cell transplantation setting: Is it time for early cessation of empirical antibiotherapy? Balkan Med J. 2017 Apr 5;34(2):132-139. doi: 10.4274/balkanmedj.2016.0012.
  40. Leblebicioglu H, Sunbul M, Guner R, Bodur H, Bulut C, Duygu F, ElaldiN, Cicek SenturkG, Ozkurt Z, YilmazG, Fletcher TE, Beeching NJ. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study. Clin Microbiol Infect. 2016 Apr;22(4):387.e1-4. doi: 10.1016/j.cmi.2015.11.024.
  41. Tufan ZK, Eser FC, Vudali E, Batirel A, Kayaaslan B, Bastug AT, Eray D, Turhan V, Duygu F, Tok D, Altun S, Bulut C, Tasyaran MA. The Knowledge of the Physicians about Sepsis Bundles is Suboptimal: A Multicenter Survey. J Clin Diagn Res. 2015 Jul;9(7):OC13-6. doi: 10.7860/JCDR/2015/12954.6220. Epub 2015 Jul 1.
  42. Gul S, Kuscu F, Aydemir H, Ozturk DB, Deveci O, Duygu F, Kacmaz B, Yaman F, Aslan E. Risk factors for colistin-associated acute kidney injury:a multicenter study from Turkey. Jpn J Infect Dis. 2015 Jul 10.
  43. Leblebicioglu H, Erben N, Rosenthal VD, Sener A, Uzun C, Senol G, Ersoz G, Demirdal T, Duygu F et al. Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC). Am J InfectControl. 2015 Jan 1;43(1):48-52. doi: 10.1016/j.ajic.2014.09.017.
  44. Ilker Inanc Balkan, Ayse Batirel, Oguz Karabay, Canan Agalar, Serife Akalin, Ozlem Alici, Emine Alp, Fatma Aybala Altay, Nilgun Altin, Ferhat Arslan, Turan Aslan, Nural Bekiroglu, Salih Cesur, Aygul Dogan Celik, Mustafa Dogan, Bulent Durdu, Fazilet Duygu et al. Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: A Multicenter retrospective analysis. Indian J Pharmacol. 2015 Jan-Feb;47(1):95-100. doi: 10.4103/0253-7613.150383
  45. Sunbul M, Leblebicioglu H, Fletcher TE, Elaldi N, Ozkurt Z, Bastug A, Yilmaz G, Guner R, Duygu F, Beeching NJ. Crimean-Congo haemorrhagic fever and secondary bacteraemia in Turkey. J Infect. 2015 Jul 18. pii: S0163-4453(15)00226-1. doi: 10.1016/j.jinf.2015.07.003.
  46. Batirel A, Balkan II, Karabay O, Agalar C, Akalin S, Alici O, Alp E, Altay FA, Altin N, Arslan F, Aslan T, Bekiroglu N, Cesur S, Celik AD, Dogan M, Durdu B, Duygu F, Engin A, Engin DO, Gonen I, Guclu E, Guven T, Hatipoglu CA, Hosoglu S, Karahocagil MK, Kilic AU, Ormen B, Ozdemir D, Ozer S, Oztoprak N, Sezak N, Turhan V, Turker N, Yilmaz H. Comparison of Colistin-Carbapenem, Colistin-Sulbactam and Colistin-Other Antibacterial Agents for Treatment of Extremely drug- resistant Acinetobacter baumannii Bloodstream Infections. Eur J Clin Microbiol Infect Dis DOI 10.1007/s10096-014-2070-6
  47. Ozturk-Engin D, Erdem H, Gencer S, Kaya S, Baran AI, Batirel A, Tekin R, Celen MK, Denk A, Guler S, Ulug M, Turan H, Pekok AU, Mermut G, Kaya S, Tasbakan M, Tulek N, Cag Y, Inan A, Yalci A, Ataman-Hatipoglu C, Gonen I, Dogan-Celik A, Bozkurt F, Gulsun S, Sunnetcioglu M, Guven T, Duygu F, Parlak E, Sozen H, Tosun S, Demirdal T, Guclu E, Karabay O, Uzun N, Gunal O, Diktas H, Haykir-Solay A, Erbay A, Kader C, Aydin O, Erdem A, Elaldi N, Kadanali A, Yulugkural Z, Gorenek L, Altındis M, Bolukcu S, Agalar C, Ormeci N. Liver involvement in patients withbrucellosis: results of the Marmara study. Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1253-62. doi: 10.1007/s10096-014-2064-4.
  48. Erdem H, Ozturk-Engin D, Yesilyurt M, Karabay O, Elaldi N, Celebi G, Korkmaz N, Guven T, Sumer S, Tulek N, Ural O, Yilmaz G, Erdinc S, Nayman-Alpat S, Sehmen E, Kader C, Sari N, Engin A, Cicek- Senturk G, Ertem-Tuncer G, Gulen G, Duygu F et al. Evaluation of tularaemia courses: a multicentre study from Turkey. Clin Microbiol Infect. 2014 Dec;20(12):O1042-51. doi: 10.1111/1469-0691.12741. Epub 2014 Aug 13.
  49. Erdem H, Elaldi N, Ak O, Gulsun S, Tekin R, Ulug M, Duygu F, Sunnetcioglu M et al. Genitourinary brucellosis: results of a multicentric study. Clin Microbiol Infect. 2014 Nov;20(11):O847-53. doi: 10.1111/1469-0691.12680. Epub 2014 Jul 12.
  50. A. Ulu-Kilic, A. Karakas, H. Erdem, T. Turker, A. S. Inal, O. Ak, H. Turan, E. Kazak, A. Inan, F. Duygu, H. Demiraslan, C. Kader, A. Sener, S. Dayan, O. Deveci, R. Tekin, N. Saltoglu, M. Aydın, E. S. Horasan, H. C. Gul, B. Ceylan,A.Kadanalı, O. Karabay,G. Karagoz, U. Kayabas, V. Turhan, D.Engin, S. Gulsun,N. Elaldı and S. Alabay. Update on Treatment Options for Spinal Brucellosis. Clin Microbiol Infect. 2014 Feb;20(2):O75-82. doi: 10.1111/1469-0691.12351.
  51. Basol N, Duygu F, Gökbakan AM, Alatli T. Anxiety experienced in the fear of disease: Tick bite and crimean-congo hemorrhagic fever. Acta Medica Mediterranea 30, 691-696
  52. Kalkan G, Seçkin HY, Duygu F, Akbaş A, Ozyurt H, Sahin M. Oxidative stress status in patients with acute urticaria. Cutaneous and Ocular Toxicology 2013 Jul 10. [Epub ahead of printa]
  53. Gunal O, Barut Ş, Sogut E, Duygu F, Etikan I, Parlak E, Atay A. Neopterin, Procalcitonin, High- sensitivity C-Reactive Protein Concentrations and Erythrocyte Sedimentation Rates of Patients with Brucellosis and Extracellular Bacterial Infections. TurkishJournal of Biochemistry. 2014; 39 (1) ; 37–2.doi: 10.5505/tjb.2014.72602
  54. Günal O, Barut S, Etikan İ, Duygu F, TuncelU, Sünbül M. Relation BetweenSerum Quantitative HBsAg, ALT and HBV DNA LevelsIn HBeAg NegativeChronic HBV Infection. The Turkish Journal of Gastroenterology. Turk J Gastroenterol. 2014 Dec;25 Suppl 1:142-6. doi: 10.5152/tjg.2014.5711.
  55. Başol N, Duygu F, Ayan M. Detailed Evaluation of Patients Admitted to Emergency Department with Tick Bite Complaint. Medicina (Kaunas). 2013;49(8):367-71.
  56. Pancar GS, Duygu F, Kalkan G. The prognostic role of the new entity butterfly-like facial rash and cutaneous findings in patients with crimean congo haemorrhagic fever. Journal of the European Academy of Dermatology and Venereology. 21 Mar 2013 DOI: 10.1111/jdv.12145
  57. Hakan Erdem, Asuman Inan, Nazif Elaldi, Recep Tekin, Serda Gulsun, Cigdem Ataman- Hatipoglu, Nicholas Beeching, Özcan Deveci, Aysun Yalci, Sibel Bolukcu, Ozgur Dagli, Abdullah Umut Pekok, Ibrahim Erayman, Figen Kaptan, Selcuk Kaya, Aykut Cilli, Ayşe Batirel, Behice Kurtaran, Mehmet Ulug, Bilgehan Aygen, Mehmet Cabalak, Birsen Cetin, Gonul Cicek-Senturk, Fazilet Duygu et al. Respiratory SystemInvolvement In Brucellosıs: The Results Of The Kardelen Study. Chest. 2013 Aug 1. doi: 10.1378/chest.13-0240.
  58. Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, Kübler A, Viet-Hung N, Ramírez-Wong FM, Portillo-Gallo JH, Toscani J, Gikas A, Dueñas L, El-Kholy A, Ghazal S, Fisher D, Mitrev Z, Gamar-Elanbya MO, Kanj SS, Arreza-Galapia Y, Leblebicioglu H, Hlinková S, Memon BA, Guanche-Garcell H, Gurskis V, Alvarez-Moreno C, Barkat A, Mejía N, Rojas-Bonilla M, Ristic G, Raka L, Yuet-Meng C; International Nosocomial Infection Control Consortiuma. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol. 2013 Jun;34(6):597-604. doi: 10.1086/670626.
  59. H Karsen,F Duygu, K Yapıcı, Aİ Baran, H Taskıran, İ Binici. Severe Thrombocytopenia and Hemorrhagic Diathesis due to Brucellosis. Arch Iran Med. 2012 May;15(5):303-6.
  60. Karsen H, Tekin Koruk S, Duygu F, Yapici K, Kati M. Review of 17 cases of neurobrucellosis: clinical manifestations, diagnosis, and management. Arch Iran Med. 2012 Aug;15(8):491-4.
  61. Koc S, Sogut E, Duygu F, Gurbuzler L, Eyibilen A, Aladag I. Evaluation of oxidative stress in patients with tularemia. African Journal of Microbiology Research 2012; 6(24):121-125. DOI: 10.5897/AJMR11.1007
  62. Koç S, Duygu F, Söğüt E, Gürbüzler L, Eyibilen A, Aladağ I. Clinical and laboratory findings of tularemia: a retrospective analysis. Kulak Burun Boğaz Ihtis Derg. 2012;22(1):26-31. doi: 10.5606/kbbihtisas.2012.005.
  63. Koc S, Aksoy N, BilincH, Duygu F, IO Uysal , A Ekinci.Paraoxonase and arylesterase activityand total oxidative/anti-oxidative status in patients with chronic adenotonsillitis. Int J Pediatr Otorhinolaryngol. 2011 Nov;75(11):1364-7. Epub 2011 Sep 3. DOI: 10.1016/j.ijporl.2011.07.017
  64. Koç S, Duygu F, Eyibilen A, Aksoy N, Taskin A, Bilinc H. The role of Paraoxanase-1 in the development of acute otitis media. Journal of Clinical and Experimental Investigations. 2011; 2(4):412-415doi: 10.5799/ahinjs.01.2011.04.0083
  65. Karsen H, Sökmen N, Duygu F, Binici İ. The false sero-negativeness of brucella standart agglutination test: Prozone phenomenon. J Microbiol Infect Dis 2011;1 (3); 110-113 doi: 10.5799
  66. Duygu F, Balci PO, Solmaz M, Sefa Ucar N. Meningitis Associated With Vancomycin Resistant Enterococcus casseliflavus: First Report. Journalof Microbiology and Infectious Diseases 2011; 1 (3): 138-140. doi: 10.5799
  67. Mert D, IskenderG, Duygu F, Merdin A, Dal Mehmet S, Dogan M, Tekgündüz E,Ertek M, Altuntaş F. Invasive Aspergillosis with Disseminated Skin Involvement in a Patient with Acute Myeloid Leukemia: A Rare Case. Hematol Rep. 2017 Jun 1;9(2):6997. doi: 10.4081/hr.2017.6997. eCollection 2017 Jun 1. PubMed PMID:28626542; PubMed Central PMCID: PMC5472346.
  68. Ceken S, İskenderG, Ogan MC, Duygu F, Ertek M. Thyroiditis During Pegylated Interferon Therapy and HbsAg Seroconvertion after the Treatment. Acta Onkologica Turcica2016;49(3):212-215 DOI: 10.5505/aot.2016.89421
  69. Kalkan G, Duygu F, Bas Y. Greenish-blue stainingof underclothing due to Pseudomonas aeruginosa infection of intertriginous dermatitis. J Pak Med Assoc. 2013 Sep;63(9):1192-4.
  70. Koruk ST, Duygu F, Gursoy B, Karaagac L, Bayraktar M. A Rare Case of Seronegative Neurobrucellosis. Ann Saudi Med. 2010 Sep-Oct;30(5):412-4.
     
  71. Duygu F. Syrian Children’s Health in Turkey (Türkiye’de doğan Suriyeli çocuklarve sağlık) SD Medical Journal. 2016;40:40-41
  72. Karsen H, Duygu F, Geylan H, Demirtas M, Sunnetcioglu M, Satici A. Eyelids Involvement of Cutaneous Anthrax. Turkiye Klinikleri J Ophthalmol. 2011;20(3):141-4.
  73. İskender G , Çeken S, Oğan MC, Gedik H, Duygu F, Ertek M. Invasive Device Related Nosocomial Infections in Adult Intensive Care Unit of an Oncology Hospital: Evaluation of Five Years. 2016;49(1):27-34. DOI 10.5505/aot.2016.48030
  74. Duygu F, Uçar H, Balcı PÖ, Solmaz M. Evaluation of Literature on Account of a Vancomycin Resistant Enterococcus Outbreak, and New Practices, Turkish Journal of Hospital Infection 2012;16(4):183-189.
  75. Koç S, Duygu F, İbrahim Aladağ. Specific Diseases of the Oropharynx. Turkiye Klinikleri J E.N.T.- Special Topics. 2012;5(4):70-4
  76. Çiçek A, Duygu F,Mızraklı A. Evaluation of parasitological examination of stools in the Microbiology Laboratory of the Sanliurfa Education and Research Hospital. Harran University Medical Journal. 2011 8(1):22-24
  77. Koruk ST, Duygu F,Karaağaç L, Koruk İ, ÇakmakA, Sırmatel F. The Evaluation of the Characteristics of the Children Followed with the Diagnosis of Chronic Hepatitis B in Harran University Research Hospital. Journal of viral hepatitis. 2010;16(3): 87-92.
  78. Duygu F,Koruk ST, GürsoyB, Yıldız S, Bayraktar M. Bölgemizde sık görülen bir hastalığın nadir klinik formu: Nörobruselloz- Olgu sunumu. Harran Üniversitesi Tıp Fakültesi Dergisi, 2009; Cilt 6, Sayı 2 13-14.
  79. Sırmatel F, Duygu F, Hakim Çelik, Şahabettin Selek, Öcal Sırmatel, Bensu Gürsoy, Fatma Eriş. Evaluation of Total Oxidative Level and Total Antioxidant Capacity in Cases with Chronic Viral Hepatitis. Klimik Journal 2009; 22(3): 92-6.
  80. Koruk ST, Koruk I, Şahin M, Duygu F. Evaluation of HBsAg, Anti-HBs and Anti-HCVPositivity and Risk FactorsAmong Oral and Dental Health Workers in Şanliurfa. Klimik Journal 2009; 22(2):55-61

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Information icon

Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen

Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte überprüfen Sie die Details in der Datenschutzerklärung und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.